TrialHepatology international2021

First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients.

Jee-Fu Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.